Photo Gallery

Login

Search

News & Updation

  • WJPPS FEBRUARY ISSUE PUBLISHED
  • FEBRUARY 2019 Issue has been successfully launched on 1 February 2019

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.647 to 7.421 due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  

Abstract

SYNTHESIS, CHARACTERISATION AND IN VITRO ANTICANCER ACTIVITY OF SOME BENZIMIDOTHIAZOLIDINONE DERIVATIVES

Reshma P. T.* and Jishaprems

ABSTRACT

Benzimidazole derivatives plays an important role in medical field with so many pharmacological activities. A series of novel benzimidazole substituted Schiff bases were synthesized by reaction of 2-amino benzimidazoles with corresponding aromatic aldehydes. The prepared Schiff bases were reacted with thioglycolic acid to form correspondingthiazolidinone derivatives. The synthesized title compounds were characterized by means of their FT-IR, ┬╣HNMR and ESI MS spectroscopy. The above synthesized title compounds were tested for in vitro anticancer activity against HCT-116 cell line and PaCa MIA cell line. Among the tested compounds, the compounds 3NB(3-[4-(1H-benzimidazol-2-yl)phenyl]-5-(3-nitrophenyl)-1,3- thiazolidin-4-one) and PFB(3-[4(1H-benzimidazol-2-yl)phenyl]-5-(4-fluorophenyl)-1,3-thiazolidin-4-one) exerted significant activity in HCT-116 celllines at micro molar concentration. Compound PFB (3-[4(1H-benzimidazol-2-yl) phenyl]-5-(4-fluoro phenyl)-1, 3-thiazolidin-4-one), and compound 2CB3-[4-(1H-benzimidazol-2-yl)phenyl]-5-(2- chloro phenyl)-1,3- thiazolidin-4-one have significant activity against PACA MIA cell lines. This may due to presence of electronegative atoms in the benzimidothiazolidinone ringprobably interacts with a specific target molecule to inhibit cell growth.

Keywords: Benzimidazole, Schiff reaction, benzimidothiazolidinone, anticancer, MTT assay.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More